Christopher Beck

Mr. Beck is Vice President, Intellectual Property at Arvinas. He has over 20 years of experience building IP portfolios, guiding IP transactions, and setting IP strategies for life science companies.

Mr. Beck joins Arvinas after serving as Vice President and Head of Intellectual Property at Akebia Therapeutics where he led Akebia’s IP team, developed the IP strategy for both commercial products and clinical stage assets, and directed U.S. and international IP litigation and adversarial proceedings.

Prior to Akebia, Mr. Beck held several positions within the Danaher family of companies, most recently as Chief IP Counsel of the Danaher Innovation Center, which made investments in emerging technologies in the life science and diagnostics fields.

Prior to that, Mr. Beck served as Chief IP Counsel at Forum Pharmaceuticals and Senior Patent Counsel at Genzyme Corporation.

Mr. Beck received his B.S. in Chemistry from The Ohio State University, his Ph.D. in Chemistry from Yale University, and his J.D. from George Washington University Law School.